Boston Scientific Logo

Ureteroscopy

A ureteroscopy is usually performed with an endoscope that is passed through the urethra, bladder, and then directly into the ureter, in order to diagnose and treat disorders such as kidney stones. The examination may be performed with either a flexible or a rigid fiberoptic device while the patient is under a general anesthetic.
Contact Us About This Procedure
HEALTH CARE PROFESSIONALS
Prescriptive Information

Prescriptive Information

Indications

Indicated for extrinsic compression of ureter, ureteral obstruction, ureteral trauma, ureteral manipulation, preparation for ureteral manipulation and assistance with stone fragment passage.

Contraindications

Contraindicated for poor surgical risk patients, unexplained hematuria and un-repaired ureteral avulsion.

Warnings

For single use only. Do not reuse, reprocess or resterilize.

Potential Adverse Effects

The Potential Complications, which may result from a ureteral stent procedure, include ureteral reflux, extravasation, cathter occlusion, catheter dislodgment, hemorrhage, sepsis, perforation of the urinary tract, and peritonitis. Products with HydroPlus Coating may cause slight irritation in some individuals.

Cautions

NOTE: Where long-term use is indicated, it is recommended that indwelling time not exceed 365 days. This stent should be evaluated by the physician on or before 90 days postplacement.

Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

Trademark

Percuflex, Contour, Hydro Plus, and Nautilus are trademarks of Boston Scientific Corporation or its affiliates.


Prescriptive Information

Indications

Indicated for use for catheterization of the urinary tract during interoperative procedures, including but not limited to ureteral occlusion for injection of contrast medium, delivery of irrigation fluids to the ureter, drainage of fluids from the urinary tract, and access, advancement or exchange of ancillary devices including guidewires.

Contraindications

Contraindicated for patients unsuitable for catheterization.

Warnings

For single use only. Do not reuse, reprocess or resterilize.

Potential Adverse Effects

The Potential Complications may include extravasation, hemorrhage, sepsis, edema, loss of renal function, perforation of kidney, renal pelvis, ureter and bladder, peritonitis, and unrinary tract infection.

Cautions

Indwelling not to exceed 24 hours.

Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

Trademark

.


Prescriptive Information

Indications

This basket is intended to be used endoscopically to grasp, manipulate and remove calculi from the urinary tract.

Contraindications

• Pregnancy • Renal malignancy • Sepsis • Anticoagulation or bleeding disorders • Presence of very large stones that in the past have failed lithotripsy with basket retrieval

Warnings

• The use of this device should be restricted to use by or under the supervision of physicians trained in urological endoscopic procedures. • Exercise care to prevent perforation or trauma of the linings of the urinary tract and associated tissues. • Some stones may be too large to be removed endoscopically with the stone retrieval basket. Use fluoroscopy or x-ray to determine the size of the stone prior to instrumentation. Do not use the basket if the stone is too large to be removed endoscopically. To do this may result in stone impaction and patient injury. • If resistance is encountered while attempting to withdraw the basket, DO NOT EXERT EXCESSIVE FORCE. • Do not fire the laser directly upon the basket. • If a basket wire is broken during lasing, discontinue lasing immediately. Good surgical procedures should be followed for basket removal. • This basket has no serviceable parts. Do not attempt to repair or alter the device. Do not resterilize the device. Any use of the device other than those indicated is not recommended. • Do not use this basket without the pre-packaged scope adapter. Doing so may result in inability to advance the laser fiber through the working channel of the scope. • This device must not come in contact with any electrified instrument.

Potential Adverse Effects

Potential complications generally recognized with the use of stone retrieval basket devices include, but are not limited to: • Pregnancy • Renal malignancy • Sepsis • Anticoagulation or bleeding disorders • Presence of very large stones that in the past have failed lithotripsy with basket retrieval • Edema • Stone impaction • Entrapment • Stone migration • Evulsion • Urinary frequency • Fever • Urinary tract infection • Hemorrhage • Pain • Ureteral trauma (including stripping, abrasion or perforation There may be other potential adverse events that are unforeseen at this time.

Cautions

PRECAUTION: Before using, inspect the blister pouch for any breach of the package to ensure a sterile product and inspect product for any damage. If seal has been broken or product is damaged. DO NOT USE. Immediately return package and product to your Boston Scientific representative. Kinks in the sheath will hinder the mechanical operation of the basket. It is recommended that the ureter be pre-dilated before endoscopy and stone retrieval to prevent impaction when retracting the stone.

Trademark

SlimLine and SLimLine EZ are trademarks of Lumenis Ltd. Sharplan is a trademark of Laser Industries, Ltd.


Prescriptive Information

Indications

The Stone Cone Device is intended to be used endoscopically to entrap and remove calculi and other foreign objects from the urinary tract.

Contraindications

No contraindications are known.

Warnings

For single use only. Do not reuse, reprocess, or resterilize.

Potential Adverse Effects

The Potential Complications that may result from use of the Stone Cone are perforation, entrapment, evulsion, hemorrhage, edema, stone migration, and stone impaction.

Cautions

Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

Trademark

Stone Cone is a registered trademark of Med Source Technologies.


Prescriptive Information

Indications

The Urological Retrieval Devices are intended to be used during urological procedures to endoscopically grasp, manipulate and remove calculi and other foreign objects.

Contraindications

Some objects may be too large to be removed endoscopically with a retrieval device. To avoid stone impaction, fluoroscopy or x-ray should be used to determine the size of the object; do not use the retrieval device if the object is too large to be removed endoscopically or to be held within the device.

Warnings

For single use only. Do not reuse, reprocess or resterilize. This device must not come in contact with any electrified instrument. This device should not be directly fired upon by a laser or lithotripter; to do so may damage the device and could result in patient injury.

Potential Adverse Effects

The Potential Complications, which may result from a urological retrieval procedure, include perforation, entrapment, evulsion, hemorrhage, and edema.

Cautions

Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physcian.


Prescriptive Information

Refer to the operator's manual for complete instructions for use.

Indications
Urology indications:

The following applications are indicated for urology while using the Ho:YAG wavelength:
  • Endoscopic transurethral incision of the prostate (TUIP), bladder neck incision of the prostate (BNI), holmium laser ablation of the prostate (HoLAP), holmium laser enucleation of the prostate (HoLEP), holmium laser resection of the prostate(HoLRP),hemostasis, vaporization and excision for treatment of benign prostatic hypertrophy (BPH). The clinical procedure for HoLRP, along with clinical study results, is described in Appendix A of the operator manual.
  • Open and endoscopic urological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue) including treatment of:
    • Superficial and invasive bladder, urethral and ureteral tumors
    • Condylomata
    • Lesions of external genitalia
    • Urethral and penile hemangiomas
    • Urethral strictures
    • Bladder neck obstructions
Contraindications
Urology contraindications

The Ho:YAG wavelength should not be used for HoLRP for treatment of BPH in patients with:
  • Carcinoma of the prostate
  • Desire for future fertility
The Ho:YAG wavelength should not be used in patients with the following conditions:
  • Inability to receive endoscopic treatment
  • Intolerance to anesthesia
Warnings
Refer to operators manual provided with product for a complete list of warnings.
General warning:
Lasers generate a highly concentrated beam of light which may cause injury if improperly used. To protect the patient and operating personnel, the entire laser and the appropriate delivery system operator manuals, including all Safety and Regulatory sections, should be carefully read and comprehended before operation.

Urology warnings:
Good clinical judgement should be used prior to performing the HoLRP procedure on patients who are taking anticoagulants.

Potential Adverse Effects
General laser complications

  • Refer to complications specific to each surgical specialty and wavelength in the "Directions for Use"
  • The potential complications encountered in endoscopic laser surgery are the same as those normally encountered in conventional endoscopic surgery.
  • Acute pain may occur immediately following laser therapy and may persist for as long as 48 hours.
  • Immediately following laser therapy, the patient may experience fever and leukocytosis, which are commonly associated with tissue destruction. These generally resolve without treatment.
  • Laser ablated tissue may become necrotic or infected after treatment
  • If a question of infection exists, appropriate treatment should be carried out.

    The following complications could be serious and could result in death:
    • Patients may experience bleeding at the site of laser therapy. Posttreatment hematocrits are recommended to identify this potential complication.
    • Sepsis can result from performing any surgical procedure. If a question of sepsis exists, appropriate evaluations should be made.
    • Perforation may occur as a result of laser treatment. To diagnose perforations, patients must be carefully followed post-operatively with appropriate tests.
    Cautions
    Federal (USA) law and governing law outside the USA restrict these devices to sale by or on the order of a physician.
    Urology precautions
    The following precautions are suggested when using the Ho:YAG wavelength in urology:
    • Care should be exercised so as not to over distend the bladder when using the laser endoscopically. Excessive bladder distention could result in coagulative necrosis of the superficial and inner muscular region of the bladder wall. The following precautions are recommended for HoLRP for treatment of BPH:
    • Confirm that the tip of the fiber optic delivery device extends at least 1.25 centimeters beyond the end of the urethroscope or endoscope during laser treatment.
    • Activating the laser when the tip of the delivery device is within the urethroscope or endoscope can result in penetration of holmium laser energy through the scope and destruction of the scope.
    • Use caution during laser treatment near the verumontanum.
    • The learning curve to obtain proficiency in HoLRP has been described by experienced urologists to be similar to that of learning TURP
    Read “Directions for Use” for a list of additional precautions. Trademark
    Legal Manufacturer: Lumenis. Ltd. Distributed in the U.S. by: Boston Scientific Corporation. VersaPulse, VersaPulse Select, PowerSuite and Duotome are trademarks of Lumenis Ltd. Copyright: 2007 Boston Scientific Corporation or its affiliates. All rights reserved


    Prescriptive information

    Refer to the operator's manual for complete instructions for use.

    Indications
    Urology indications:

    The following applications are indicated for urology while using the Ho:YAG wavelength:
    • Endoscopic transurethral incision of the prostate (TUIP), bladder neck incision of the prostate (BNI), holmium laser ablation of the prostate (HoLAP), holmium laser enucleation of the prostate (HoLEP), holmium laser resection of the prostate(HoLRP),hemostasis, vaporization and excision for treatment of benign prostatic hypertrophy (BPH). The clinical procedure for HoLRP, along with clinical study results, is described in Appendix A of the operator manual.
    • Open and endoscopic urological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue) including treatment of:
      • Superficial and invasive bladder, urethral and ureteral tumors
      • Condylomata
      • Lesions of external genitalia
      • Urethral and penile hemangiomas
      • Urethral strictures
      • Bladder neck obstructions
    Contraindications
    Urology contraindications

    The Ho:YAG wavelength should not be used for HoLRP for treatment of BPH in patients with:
    • Carcinoma of the prostate
    • Desire for future fertility
    The Ho:YAG wavelength should not be used in patients with the following conditions:
    • Inability to receive endoscopic treatment
    • Intolerance to anesthesia
    Warnings
    Refer to operators manual provided with product for a complete list of warnings.
    General warning:
    Lasers generate a highly concentrated beam of light which may cause injury if improperly used. To protect the patient and operating personnel, the entire laser and the appropriate delivery system operator manuals, including all Safety and Regulatory sections, should be carefully read and comprehended before operation.

    Urology warnings:
    Good clinical judgement should be used prior to performing the HoLRP procedure on patients who are taking anticoagulants.

    Potential Adverse Effects
    General laser complications

    • Refer to complications specific to each surgical specialty and wavelength in the "Directions for Use"
    • The potential complications encountered in endoscopic laser surgery are the same as those normally encountered in conventional endoscopic surgery.
    • Acute pain may occur immediately following laser therapy and may persist for as long as 48 hours.
    • Immediately following laser therapy, the patient may experience fever and leukocytosis, which are commonly associated with tissue destruction. These generally resolve without treatment.
    • Laser ablated tissue may become necrotic or infected after treatment
    • If a question of infection exists, appropriate treatment should be carried out.

      The following complications could be serious and could result in death:
      • Patients may experience bleeding at the site of laser therapy. Posttreatment hematocrits are recommended to identify this potential complication.
      • Sepsis can result from performing any surgical procedure. If a question of sepsis exists, appropriate evaluations should be made.
      • Perforation may occur as a result of laser treatment. To diagnose perforations, patients must be carefully followed post-operatively with appropriate tests.
      Cautions
      Federal (USA) law and governing law outside the USA restrict these devices to sale by or on the order of a physician.
      Urology precautions
      The following precautions are suggested when using the Ho:YAG wavelength in urology:
      • Care should be exercised so as not to over distend the bladder when using the laser endoscopically. Excessive bladder distention could result in coagulative necrosis of the superficial and inner muscular region of the bladder wall. The following precautions are recommended for HoLRP for treatment of BPH:
      • Confirm that the tip of the fiber optic delivery device extends at least 1.25 centimeters beyond the end of the urethroscope or endoscope during laser treatment.
      • Activating the laser when the tip of the delivery device is within the urethroscope or endoscope can result in penetration of holmium laser energy through the scope and destruction of the scope.
      • Use caution during laser treatment near the verumontanum.
      • The learning curve to obtain proficiency in HoLRP has been described by experienced urologists to be similar to that of learning TURP
      Read “Directions for Use” for a list of additional precautions. Trademark Legal Manufacturer: Lumenis. Ltd. Distributed in the U.S. by: Boston Scientific Corporation. VersaPulse, VersaPulse Select, PowerSuite and Duotome are trademarks of Lumenis Ltd. Copyright: 2006 Boston Scientific Corporation or its affiliates. All rights reserved


      Prescriptive Information

      Indications

      The Urological Retrieval Devices are intended to be used during urological procedures to endoscopically grasp, manipulate and remove calculi and other foreign objects.

      Contraindications

      Some objects may be too large to be removed endoscopically with a retrieval device. To avoid stone impaction, fluoroscopy or x-ray should be used to determine the size of the object; do not use the retrieval device if the object is too large to be removed endoscopically or to be held within the device.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. This device must not come in contact with any electrified instrument. This device should not be directly fired upon by a laser or lithotripter; to do so may damage the device and could result in patient injury.

      Potential Adverse Effects

      The potential complications, which may result from a urological retrieval procedure, include perforation, entrapment, evulsion, hemorrhage, and inability to disengage from irretrievable object, edema, and basket inversion.

      Cautions

      Before using, inspect the sterile barrier for any breach of the package to ensure a sterile product and inspect product for any damage. If seal has been broken or product is damaged DO NOT USE. Immediately return package and product to Boston Scientific. If resistance is encountered during advancement or withdrawal of device, DO NOT EXERT EXCESSIVE FORCE.

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.




      Prescriptive Information

      Indications

      The Ureteral Stent is intended to facilitate drainage from the kidney to the bladder.

      Contraindications

      Contraindicated for poor surgical risk patients, unexplained hematuria and un-repaired ureteral avulsion.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize.

      Potential Adverse Effects

      The Potential Complications, which may result from a ureteral stent procedure, include ureteral reflex, extravasation, stent occlusion, dislodgment, hemorrhage, sepsis, perforation of the urinary tract, and peritonitis.

      Cautions

      Federal (USA) law restricts these devices to sale by or on the order of a physician.


      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.
      Indications

      The double pigtail Percuflex® ureteral stents are intended to facilitate drainage from the kidney to the bladder via placement endoscopically or fluoroscopically or during an open surgical procedure by a trained physician.

      Contraindications

      The double pigtail Percuflex ureteral stents are contraindicated for use with the following procedures and/or conditions:

    • Poor surgical risk patients

    • Unexplained hematuria

    • Unrepaired ureteral avulsion
    • Warnings

      For single use only. Do not reuse, reprocess, or resterilize.

      Potential Adverse Effects

      Potential complications associated with retrograde and antegrade positionedindwelling ureteral stents:

    • Ureteral reflux

    • Catheter occlusion

    • Catheter dislodgment

    • Hemorrhage
    • Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.


      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.
      Indications

      The Boston Scientific Urological Guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures.

      Contraindications

      No contraindications are known.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. Do not manipulate, advance and/or withdraw the guidewire through a metal cannula or needle; to do so may result in destruction and/or separation of the device, which may result in injury. Do not use a retrieval device while the guidewire is in place; to do so may cause damage to the guidewire.

      Potential Adverse Effects

      The Potential Complications, which may result from use of a guidewire in urological guidewire procedures, include perforation of the urinary tract, hemorrhage, edema, acute bleeding and tissue trauma.

      Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.


      Prescriptive Information

      Indications

      The Urological Retrieval Devices are intended to be used during urological procedures to endoscopically grasp, manipulate and remove calculi and other foreign objects.

      Contraindications

      Some objects may be too large to be removed endoscopically with a retrieval device. To avoid stone impaction, fluoroscopy or x-ray should be used to determine the size of the object; do not use the retrieval device if the object is too large to be removed endoscopically or to be held within the device.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. This device must not come in contact with any electrified instrument. This device should not be directly fired upon by a laser or lithotripter; to do so may damage the device and could result in patient injury.

      Potential Adverse Effects

      The Potential Complications, which may result from a urological retrieval procedure, include perforation, entrapment, evulsion, hemorrhage, and inability to disengage from irretrievable object, edema, and basket inversion.

      Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

      Trademark

      ZeroTip is a trademark of Boston Scientific Corporation or its affiliates.


      Prescriptive Information

      Indications

      The Urological Guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures.

      Contraindications

      No contraindications are known.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. Do not manipulate, advance and/or withdraw the guidewire through a metal cannula or needle; to do so may result in destruction and/or separation of the device, which may result in injury. A retrieving device, such as a gripper or basket forceps, should only be used after the guidewire has been removed from the patient's channel or duct. Using a retrieving device while the guidewire is in place may cause the guidewire to break.

      Potential Adverse Effects

      The Potential Complications, which may result from use of a guidewire in urological guidewire procedures, may include perforation of the urinary tract, hemorrhage, edema, acute bleeding, and tissue trauma.

      Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.


      Prescriptive Information

      Indications

      The Urological Balloon Dilatation Catheter is intended to dilate strictures of the urinary tract.

      Contraindications

      This product is contraindicated in the presence of conditions which create unacceptable risk during catheterization.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize.

      Potential Adverse Effects

      The Potential Complications, which may result from a balloon dilatation procedure, include tissue trauma and tissue perforation.

      Cautions

      If resistance is encountered during advancement or withdrawal of device, DO NOT EXERT EXCESSIVE FORCE. Do not inflate balloon dilatation catheter while balloon is directly beside the stone. Refer to package label for balloon's rated burst pressure.

      Federal (USA) law and governing law outside USA restricts these devices to sale by or on the order of a physician.

      For products with HydroPlus™ Coating: refer to package insert for instructions on preparing the product for use. Care should be exercised if passing a HydroPlus coated balloon through any metal containing systems. Do not wrap gauze around the balloon. Minimize excessive handling. Do not wipe balloon with dry gauze or gauze wet with any solvent other than sterile water or saline.




      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.

      Indications

      Intended to facilitate the drainage of urine from the kidney to the bladder.

      Contraindications

      Contraindicated for use in patients with poor surgical risk, unexplained hematuria, or unrepaired ureteral avulsion.

      Warnings

      For single use only. Do not reuse, reprocess, or resterilize.

      Potential Adverse Effects

      The Potential Complications associated with a retrograde or antegrade positioned indwelling ureteral stents may include pain, ureteral reflux, extravasation, catheter occlusion, catheter dislodgment, hemorrhage, sepsis, perforation, and peritonitis.

      Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

      Trademark

      Stretch VL and Flexima are trademarks of Boston Scientific Corporation or its affiliates.


      Prescriptive Information

      Refer to the operator's manual for complete instructions for use. Indications

      The Urological Guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures.

      Contraindications

      No contraindications are known.

      Warnings

      For single use only. Do not reuse, reprocess, or resterilize. Do not manipulate, advance and/or withdraw the guidewire through a metal cannula or needle; doing so may result in destruction and/or separation of the device, which may result in injury. Do not use a retrieval device while the guidewire is in place; doing so may cause damage to the guidewire.

      Potential Adverse Effects

      The Potential Complications, which may result from use of a guidewire in urological guidewire procedures, may include, but are not limited to: perforation of the urinary tract, hemorrhage, edema, acute bleeding, and tissue trauma.

      Cautions

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.


      Prescriptive Information

      Indications

      The Swiss LithoClast Ultra is intended for the fragmentation of urinary tract calculi in the kidney, ureter and bladder.

      Contraindications

      Contraindicated in patients with active bleeding disorders, solitary functioning kidney, creatinine greater than or equal to 3 mgm percent, during pregnancy, under the age of 18, stricture and obstruction problems, and with electrical stimulator implanted e.g. pacemaker.

      Warnings

      For single use only. Do not reuse, reprocess, or resterilize.

      Potential Adverse Effects

      The Potential Complications from use of the Swiss LithoClast Ultra may include, but are not limited to, perforation, hemorrhage, lesion, stone migration, pain/colic, macroscopic hematuria, infection, and ureteral obstruction.

      Cautions

      Federal (USA) law and governing law outside the USA restricts this device to sale by or on the order of a physician.

      Trademark

      Swiss LithoClast is a registered trademark of Ferton Holding SA

      Federal (USA) law and governing law outside the USA restricts these devices to sales by or on the order of a physician.

      Swiss LithoClast Ultra is manufactured by EMS Electro Medical Systems S.A. and distributed in the U.S. exclusively by Boston Scientific Corporation.


      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.
      Indications

      The Guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures.

      Contraindications

      No contraindications are known.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. Do not manipulate, advance and/or withdraw the guidewire through a metal cannula or needle; to do so may result in destruction and/or separation of the device, which may result in injury. Do not use a retrieval device while the guidewire is in place; to do so may cause damage to the guidewire.

      Potential Adverse Effects

      The Potential Complications, which may result from the use of a guidewire in urological guidewire procedures, include perforation of the urinary tract, hemorrhage, edema, acute bleeding, and tissue trauma.

      Cautions

      Before using, inspect the sterile barrier for any breach of the package to ensure a sterile product and inspect product for any damage. If seal has been broken or product is damaged DO NOT USE. Immediately return package and product to Boston Scientific. If resistance is encountered during advancement or withdrawal of device, DO NOT EXERT EXCESSIVE FORCE. Do not use the guidewire if it becomes damaged to do so will prevent accurate torque or tactile response and may cause injury.

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.

      Trademark

      Glidewire is a registered trademark of Terumo Corporation.


      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.
      Indications

      The Urological Retrieval Devices are intended to be used during urological procedures to endoscopically grasp, manipulate and remove calculi and other foreign objects.

      Contraindications

      Some objects may be too large to be removed endoscopically with a retrieval device. To avoid stone impaction, fluoroscopy or x-ray should be used to determine the size of the object; do not use the retrieval device if the object is too large to be removed endoscopically or to be held within the device.

      Warnings

      For single patient use only. Do not reuse, reprocess or resterilize. This device must not come in contact with any electrified instrument. This device should not be directly fired upon by a laser or lithotripter; to do so may damage the device and could result in patient injury.

      Potential Adverse Effects

      The potential complications, which may result from a urological retrieval procedure, include perforation, entrapment, evulsion, hemorrhage, inability to disengage from irretrievable object, edema, and basket inversion.

      Cautions

      Before using, inspect the sterile barrier for any breach of the package to ensure a sterile product and inspect product for any damage. If seal has been broken or product is damaged DO NOT USE. Immediately return package and product to Boston Scientific. If resistance is encountered during advancement or withdrawal of device, DO NOT EXERT EXCESSIVE FORCE.

      Federal (USA) law and governing law outside the USA restricts these devices to sale by or on the order of a physician.




      Prescriptive Information

      Refer to the operator's manual for complete instructions for use.

      Indications

      The Polaris Loop Ureteral Stents are intended to facilitate drainage from the kidney to the bladder via placement endoscopically, fluoroscopically, or during an open surgical procedure by a trained physician.

      Contraindications

      The Polaris Loop Ureteral Stents are contraindicated for use with the following procedures and/or conditions:

      • Antegrade placement
      • Poor surgical risk patients
      • Unexplained hematuria
      • Unrepaired ureteral avulsion

      Warnings

      Contents supplied STERILE using an ethylene oxide (EO) process. Do not use if sterile barrier is damaged. If damage is found call your Boston Scientific representative. For single patient use only. Do not reuse, reprocess or resterilize. Reuse, reprocessing or resterilization may compromise the structural integrity of the device and/or lead to device failure which, in turn, may result in patient injury, illness or death. Reuse, reprocessing or resterilization may also create a risk of contamination of the device and/or cause patient infection or cross-infection, including, but not limited to, the transmission of infectious disease(s) from one patient to another. Contamination of the device may lead to injury, illness or death of the patient. After use, dispose of product and packaging in accordance with hospital, administrative and/or local government policy.

      Potential Adverse Effects

      Potential complications associated with retrograde positioned indwelling ureteral stents:

      • Edema
      • Extravasation
      • Fistula formation
      • Hemorrhage
      • Hydronephrosis
      • Infection
      • Loss of renal function
      • Pain/discomfort
      • Perforation of kidney, renal pelvis, ureter, and/or bladder
      • Peritonitis
      • Stent dislodgement/fragmentation/migration/occlusion
      • Stent encrustation
      • Stone formation
      • Ureteral erosion
      • Ureteral reflux
      • Urinary symptoms (frequency, urgency, incontinence, dysuria, hematuria)

      Cautions

      • Retrieval line indwelling time should not exceed fourteen(14) days to avoid possible cord encrustation
      • Recommended for one time use only
      • Bending or kinking during or prior to placement could damage the integrity of the stent
      • If resistance is encountered during advancement or withdrawal of the stent, STOP. Do not continue without first determining the cause of the resistance and taking remedial action
      • It is recommended that when long term use is indicated the stent should be evaluated every 90 days
      • Results from laboratory testing demonstrate that the stent material (Percuflex™) is biocompatible for up to 365 days.
      • During cystoscopic placement the Polaris™ Loop Stent requires a 12 F (4.0 mm) or greater bridgeport in conjunction with a 19.5 F (6.5 mm) or larger sheath.
      • During stent removal it is recommended to grasp both loops prior to extracting the stent.
      • The recommendations given here are meant to serve only as a basic guide to the utilization of this stent. The insertion of the ureteral stent should not be undertaken without comprehensive knowledge of the indications, techniques and risks of the procedure.
      Federal (USA) law and governing law outside the USA restrict these devices to sale by or on the order of a physician.

      *Data on file at Boston Scientific for a 236 subject clinical trial at 13 investigation sites located throughout USA and Canada.


      Prescriptive Information

      Indications

      The Navigator Ureteral Access Sheath is indicated for use in endocsopic procedures to facilitate the passage of endoscopes, urological instruments and for the injection of fluids into the urinary tract.

      Contraindications

      Patients who are contraindicted for Retrograde urologic procedures; Presence of tight strictures which would limit use of the device; Presence of large obstructing distal ureteral stone.

      Warnings

      The recommendations given are meant to serve only as a basic guide to the utilization of this access sheath set. The ureteral sheath set should not be used without comprehensive knowledge of the indications, techniques and risks of the procedure.

      To minimize resistance during advancement, ensure the hydrophilic coating on the dilator and sheath is activated with saline or sterile water prior to placement.

      • DO NOT bend or kink the catheter prior to placement, to do so could damage the integrity of the catheter and result in patient injury.
      • If resistance is encountered during advancement or withdrawal of the catheter, STOP. DO NOT continue without first determining the cause of the resistance and taking remedial action.
      • DO NOT advance the sheath without the dilator in place, to do so could cause injury to the patient.

      Potential Adverse Effects

      Potential complications associated with the use of the transurethral access device include, but not limited to: mucosal irritation, inflammation and edema; uretheral strictures; acute bleeding or hemorrhage; urethral, bladder, or ureteral perforation; other injury to the urinary tract.

      Cautions

      To minimize resistance during advancement, ensure the hydrophilic coating on the dilator and sheath is activated with saline or sterile water prior to placement. DO NOT bend or kink the catheter prior to placement, to do so could damage the integrity of the catheter and result in patient injury. If resistance is encountered during advancement or withdrawal of the catheter, STOP. DO NOT continue without the dilator in place, to do so could cause injury to the patient. Caution: Federal law (U.S.A) restricts this device to sale, distribution and use by or on the order of a physician. Refer to the Directions for Use provided with this product for complete instructions, warnings, and precautions prior to using this product.


      Prescriptive Information

      Indications

      The Urological Retrieval Device is intended to be used during urological procedures to endoscopically grasp, manipulate and remove calculi and other foreign objects.

      Contraindications

      Some objects may be too large to be removed endoscopically with a retrieval device. To avoid stone impaction, fluoroscopy or x-ray should be used to determine the size of the object; do not use the retrieval device if the object is too large to be removed endoscopically or to be held within the device.

      Warnings

      For single use only. Do not reuse, reprocess or resterilize. This device must not come in contact with any electrified instrument. This device should not be directly fired upon by laser or lithotripter; to do so may damage the device and could result in patient injury.

      Potential Adverse Effects

      The Potential Complications, which may result from a urological retrieval procedure, include perforation, entrapment, evulsion, hemorrhage, and edema.

      Cautions

      Federal (USA) law and governing law outside the USA restricts the sale by or on the order of a physician.


      Prescriptive Information: Holmium 60W Laser

      Urology indications
      The following applications are indicated for urology while using the Ho:YAG wavelength:
      Open and endoscopic urological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue) including treatment of:
      • Superficial and invasive bladder, urethral, and ureteral tumors
      • Condylomata
      • Lesions of external genitalia
      • Urethral and penile hemangiomas
      • Urethral strictures
      • Bladder neck obstructions
          Urology contraindications
          The Ho:YAG wavelength should not be used in patients with the following conditions:
          • Inability to receive endoscopic treatment
          • Intolerance to anesthesia
          Urology warnings
          Read “General laser warnings” the operators manual for a list of warnings.
          Urology precautions
          CAUTION – Care should be exercised so as not to over distend the bladder when using the laser endoscopically. Excessive bladder distention could result in coagulative necrosis of the superficial and inner muscular region of the bladder wall.
          Read “General laser precautions” in the operators manual for a list of additional precautions.
          Urology complications
          Read “General laser complications” in the operators manual for a list of complications.
          Urinary lithotripsy indications
          The following applications are indicated for urinary lithotripsy while using the Ho:YAG wavelength:
          • Endoscopic fragmentation of urinary (urethral, ureteral, bladder and renal) calculi, including cystine, calcium oxalate, monohydrate and calcium oxalate dihydrate stones
          • Treatment of distal impacted fragments of steinstrasse when guide wires cannot be passed
          Urinary lithotripsy contraindications
          The Ho:YAG wavelength must not be used in patients with the following conditions:
          • Inability to receive endoscopic treatment
          • Intolerance to anesthesia
          Urinary lithotripsy warnings
          WARNING – Unexpected tissue damage may occur due to excessive power application. Refer to “Urinary lithotripsy clinical parameters” in the operators manual for recommended initial power settings. Use of excessive power may result in inadvertent perforation of the ureter or damage to other urologic structures. Read “General laser warnings” in operators manual for a list of additional warnings. Indications for Use Specific to the Ho:YAG Wavelength
          Urinary lithotripsy precautions
          CAUTION – The laser should be used with an optical fiber delivery system in direct view and in direct contact with the target ureteral stone. To minimize the potential for migration up the ureter, laser energy should be directed to the side of the stone, if possible, rather than the leading edge. Maintaining low energy levels and repetition rates will reduce the potential for possible stone migration.
          CAUTION – Be aware of edematous folds of epithelium that may lie between the optical fiber and the stone; however, research suggests such folds are very rare.
          CAUTION – Basketing may be used with larger stone fragments that are relatively hard or tend to escape in a retrograde fashion up the ureter. Use of endoscopes in laser procedures allows excellent viewing and minimal trauma to the ureter during fragmentation. Baskets, guide wires, and other ureteroscopic accessories may be damaged by direct contact with the laser treatment beam.
          CAUTION – The use of irrigation is recommended throughout the lithotripsy procedure to absorb any heat produced, to carry stone fragments out of the urinary system, and to enhance direct visualization. The rate of irrigation should be carefully adjusted to avoid flux of calculi into the kidney. Read “General laser precautions” in operators manual for a list of additional precautions. Indications for Use
          Urinary lithotripsy complications
          • As with other endoscopic urologic procedures, there may be urine leakage following the laser procedure.
          • The use of flexible endoscopes carries an equivalent incidence of stricture formation; these rates may improve with further advances in ureteroscope design.
          • Although rare, loss of a kidney may occur as a result of the procedure or because of the stone, itself.
          Read “General laser complications” in the operators manual for a list of additional complications.


          Prescriptive Information: SlimLine EZ Single-use Holmium Laser Fiber

          Caution: Federal Law (USA) restricts these devices to sale by or on the order of a physician.
          Refer to package insert provided with product for complete instructions for use including Indications for Use, Contraindications, Potential Complications, Warning and Cautions.

          SlimLine and SlimLine EZ are trademarks of Lumenis Ltd. SlimLine EZ is manufactured by Lumenis and distributed by Boston Scientific.


          VersaPulse PowerSuite 20W Holmium Surgical Laser

          Urology indications
          The following applications are indicated for urology while using the Ho:YAG wavelength:
          Open and endoscopic urological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue) including treatment of:
          • Superficial and invasive bladder, urethral, and ureteral tumors
          • Condylomata
          • Lesions of external genitalia
          • Urethral and penile hemangiomas
          • Urethral strictures
          • Bladder neck obstructions
              Urology contraindications
              The Ho:YAG wavelength should not be used in patients with the following conditions:
              • Inability to receive endoscopic treatment
              • Intolerance to anesthesia
              Urology warnings
              Read “General laser warnings” the operators manual for a list of warnings.
              Urology precautions
              CAUTION – Care should be exercised so as not to over distend the bladder when using the laser endoscopically. Excessive bladder distention could result in coagulative necrosis of the superficial and inner muscular region of the bladder wall.
              Read “General laser precautions” in the operators manual for a list of additional precautions.
              Urology complications
              Read “General laser complications” in the operators manual for a list of complications.
              Urinary lithotripsy indications
              The following applications are indicated for urinary lithotripsy while using the Ho:YAG wavelength:
              • Endoscopic fragmentation of urinary (urethral, ureteral, bladder and renal) calculi, including cystine, calcium oxalate, monohydrate and calcium oxalate dihydrate stones
              • Treatment of distal impacted fragments of steinstrasse when guide wires cannot be passed
              Urinary lithotripsy contraindications
              The Ho:YAG wavelength must not be used in patients with the following conditions:
              • Inability to receive endoscopic treatment
              • Intolerance to anesthesia
              Urinary lithotripsy warnings
              WARNING – Unexpected tissue damage may occur due to excessive power application. Refer to “Urinary lithotripsy clinical parameters” in the operators manual for recommended initial power settings. Use of excessive power may result in inadvertent perforation of the ureter or damage to other urologic structures. Read “General laser warnings” in operators manual for a list of additional warnings. Indications for Use Specific to the Ho:YAG Wavelength
              Urinary lithotripsy precautions
              CAUTION – The laser should be used with an optical fiber delivery system in direct view and in direct contact with the target ureteral stone. To minimize the potential for migration up the ureter, laser energy should be directed to the side of the stone, if possible, rather than the leading edge. Maintaining low energy levels and repetition rates will reduce the potential for possible stone migration.
              CAUTION – Be aware of edematous folds of epithelium that may lie between the optical fiber and the stone; however, research suggests such folds are very rare.
              CAUTION – Basketing may be used with larger stone fragments that are relatively hard or tend to escape in a retrograde fashion up the ureter. Use of endoscopes in laser procedures allows excellent viewing and minimal trauma to the ureter during fragmentation. Baskets, guide wires, and other ureteroscopic accessories may be damaged by direct contact with the laser treatment beam.
              CAUTION – The use of irrigation is recommended throughout the lithotripsy procedure to absorb any heat produced, to carry stone fragments out of the urinary system, and to enhance direct visualization. The rate of irrigation should be carefully adjusted to avoid flux of calculi into the kidney. Read “General laser precautions” in operators manual for a list of additional precautions. Indications for Use
              Urinary lithotripsy complications
              • As with other endoscopic urologic procedures, there may be urine leakage following the laser procedure.
              • The use of flexible endoscopes carries an equivalent incidence of stricture formation; these rates may improve with further advances in ureteroscope design.
              • Although rare, loss of a kidney may occur as a result of the procedure or because of the stone, itself.
              Read “General laser complications” in the operators manual for a list of additional complications.


Image Gallery
Sensor™ PTFE-Nitinol Guidewire with Hydrophilic Tip Animation Stone Cone™ Nitinol Retrieval Device